Evolent Health Inc.
EVH | NYSE
$3.69
$0 (0.00%)
At close: Sep 21, 2026, 4:00 PM ET
$3.69
$0 (0.00%)
After-hours:
Sep 21, 2026, 4:01 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.79 | -13.89 | -25.80 | -140.40 | -76.86 | -4.07 |
PEG Ratio | 0 | 0.38 | -0.05 | 3.16 | 0.85 | -0.66 |
PS Ratio | 0.24 | 0.51 | 1.87 | 1.95 | 2.62 | 1.47 |
PB Ratio | 1.10 | 1.29 | 3.44 | 3.06 | 3.43 | 2.20 |
P/FCF Ratio | 96.07 | -210.54 | 32.28 | -52.71 | 173.02 | -29.79 |
P/OCF Ratio | 11.76 | 68.75 | 25.77 | -227.74 | 61.46 | -83.91 |
OCF/S Ratio | 2.07 | 0.73 | 7.26 | -0.85 | 4.27 | -1.75 |
Debt / Equity Ratio | 2.38 | 0.71 | 0.60 | 0.55 | 0.40 | 0.58 |
Quick Ratio | 1.31 | 0.85 | 1.01 | 1.10 | 1.18 | 1.36 |
Current Ratio | 1.31 | 0.85 | 1.01 | 1.10 | 1.18 | 1.36 |
Asset Turnover | 0.99 | 1 | 0.73 | 0.74 | 0.64 | 0.63 |
Interest Coverage | -0.08 | -1.64 | -1.31 | 0.23 | -1.67 | -9.28 |
Return on Equity | -128.74% | -6.15% | -10.59% | -2.23% | -5.42% | -53.95% |
Return on Assets | -28.14% | -2.42% | -4.22% | -1.05% | -2.65% | -22.67% |
Return on Invested Capital | -0.29% | -1.95% | -1.97% | 0.08% | -4.32% | -23.62% |
Dividend Yield | 2.44% | 1.56% | 0.51% | 0.57% | 0.05% | 1.47% |
Payout Ratio | -2.08% | -32.59% | -16.63% | -77.67% | -3.46% | -5.98% |
FCF Payout Ratio | -31.81% | -43.78% | 25.63% | -17.74% | -44.11% | -43.77% |
Gross Profit Margin | 15.14% | 14.38% | 23.45% | 23.42% | 27.58% | 24.66% |
Net Profit Margin | -28.49% | -2.41% | -5.76% | -1.42% | -4.14% | -36.15% |
Pretax Profit Margin | -28.50% | -2.47% | -10.31% | -4.59% | -3.28% | -35.75% |
Operating Profit Margin | -0.24% | -1.58% | -3.63% | 0.27% | -4.67% | -28.43% |
FCF Margin | 0.25% | -0.24% | 5.80% | -3.69% | 1.52% | -4.94% |
EBITDA Margin | -19.26% | 3.32% | -1.26% | 3.24% | 6.13% | -26.04% |
Add to Watchlist
Select watchlists to add or remove EVH